A company’s clinical trial app could reduce the time it takes for pharmaceutical companies and clinical research organizations to set up a site.
The app includes a global network of principal investigators grouped by country and by therapeutic area.
DrugDev presented the app as part of the Pfizer-sponsored entrepreneur pavilion at the DIA 2012 conference in Philadelphia this week.
The UK-based company has its U.S. offices in Princeton, New Jersey. Two of the co-founders have medical degrees and one is a CRO veteran.
It uses a network of more than 67,000 independently rated investigators to help clinical teams jump-start sites. By collecting relevant documents in each region in advance, clinical teams can routinely engage with potential investigators around protocol drafts, timelines, competitive studies and recruitment expectations long before a study is ready for launch, according to a company statement.
In a survey by DrugDev of 212 large- and midsized pharmaceutical companies and CROs, the average length of time it takes to set up a clinical trial site is three to four months, with many saying they would like to shorten that time. As part of its service, the company said it coordinates a monthly teleconference with investigators to update the drug developer or CRO on study progress.
But DrugDev might make more inroads with CROs than pharmaceutical companies, if a recent survey is any indicator, in which pharmaceutical companies would prefer to keep clinical trial investigator and site selection services in house.
Candice Yarde, DrugDev
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.